Furthermore, group studies have also shown that patients with high HBV DNA levels may advance to HCC or end-stage liver disease even without a significant increase in ALT levels, irrespective of HBeAg [2,20,28]. This evidence concerns the gene GPT and hepatocellular carcinoma.